Scientists have discovered a new molecule which they say can prevent the spread of cancerous cells.
Researchers at Weill Cornell Medical College report in the online edition of the journal Nature that new anti-cancer agents break down the looping gait these cells use to migrate, stopping them in their tracks.
Mice implanted with cancer cells and treated with the small molecule macroketone lived a full life without any cancer spread, compared with control animals, which all died of metastasis.
When macroketone was given a week after cancer cells were introduced, it still blocked greater than 80 percent of cancer metastasis in mice.
These findings provide a very encouraging direction for development of a new class of anti-cancer agents that specifically stop cancer metastasis.
Dr Huang and his research team have been working on macroketone since 2003. Their work started after researchers in Japan isolated a natural substance, dubbed migrastatin, secreted by Streptomyces bacteria, that is the basis of many antibiotic drugs. The Japanese researchers noted that migrastatin had a weak inhibitory effect on tumor cell migration.
“More than 90 percent of cancer patients die because their cancer has spread, so we desperately need a way to stop this metastasis,” Dr. Huang says. “This study offers a paradigm shift in thinking and, potentially, a new direction in treatment.”
“After a lot of modifications, we made several versions that were a thousand-fold more potent than the original,” Dr Huang says. In 2005, they published a study showing that several of the new versions, including macroketone, stopped cancer cell metastasis in laboratory animals, but they didn’t know how the agent worked.
In the current study, the researchers revealed the mechanism. They found that macroketone targets an actin cytoskeletal protein known as fascin that is critical to cell movement. In order for a cancer cell to leave a primary tumor, fascin bundles actin filaments together like a thick finger. The front edge of this finger creeps forward and pulls along the rear of the cell. Cells crawl away in the same way that an inchworm moves.
Macroketone latches on to individual fascin, preventing the actin fibers from adhering to each other and forming the pushing leading edge, Dr. Huang says. Because individual actin fibers are too soft when they are not bundled together, the cell cannot move.
to read more on this please go to : Wiell Cornell Medical
Related posts:
- Drug shows effect on lung cancer tumors One in five people with lung cancer has small-cell lung...
- Drugs used to treat congestive heart failure show promise in fighting colon cancer Scientists in Sweden are reporting for the first time that...
- Off-line IGRT for a non-small cell lung tumor using Elekta Synergy Non-Small Cell Cancer of the Lung courtesy of Elekta Adenocarcinoma...
Related posts brought to you by Yet Another Related Posts Plugin.

